Imovax Rabies Market Report 2026

Imovax Rabies Market Overview

• The Imovax Rabies market growth in the historic period has been driven by high rabies fatality rates, widespread animal bite exposure • Market expansion is supported by increasing travel to rabies endemic regions, expansion of veterinary public health programs • Growth Driver: Impact Of Rising Rabies Cases On The Growth Of The Market • North America was the largest region in 2025.

What Is Covered Under Imovax Rabies Market?

Imovax rabies is an inactivated rabies vaccine that prevents rabies infection in humans. It is typically administered as a series of intramuscular injections, either for pre-exposure prophylaxis for individuals at high risk or post-exposure prophylaxis following a potential rabies exposure, such as a bite from a rabid or potentially rabid animal. The main patient demographics of imovax rabies are pediatric patients, adult patients, and high-risk groups. Pediatric patients refer to children who are at risk of rabies exposure, either due to bites from infected animals or through travel to areas where rabies is endemic. Children may require specific dosages and treatments for rabies prevention, and the imovax rabies addresses these needs with vaccines tailored for young patients. It is distributed through various channels such as hospitals. Specialty clinics, online pharmacies, and pharmacies for applications such as post-exposure prophylaxis and pre-exposure prophylaxis.

What Is The Imovax Rabies Market Growth Forecast?

The growth in the forecast period can be attributed to increasing travel to rabies endemic regions, expansion of veterinary public health programs, improved vaccine access in developing regions, rising awareness of preventive care, stronger government vaccination mandates. Major trends in the forecast period include rising demand for rabies vaccination, expansion of pre exposure immunization programs, growth in post exposure prophylaxis use, increasing focus on preventive vaccination, strengthening global rabies control initiatives.

Global Imovax Rabies Market Segmentation

1) By Patient Demographics: Pediatric Patients, Adult Patients, High-Risk Groups 2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies 3) By Application: Post-Exposure Prophylaxis, Pre-Exposure Prophylaxis

What Are The Drivers Of The Imovax Rabies Market?

The rise in rabies cases is expected to propel the growth of the imovax rabies market going forward. Rabies cases refer to instances of infection caused by the rabies virus, typically transmitted through animal bites, leading to severe neurological symptoms and often death if untreated. The rise in rabies cases is usually due to increasing contact between humans and infected animals, inadequate vaccination of pets, and lack of access to timely medical treatment in some regions. Imovax rabies prevents the onset of rabies after exposure by stimulating the immune system to produce antibodies against the virus. For instance, in April 2024, according to the South Dakota Department of Health, a US-based government agency, in 2023, around 20 animals in South Dakota were confirmed to have rabies, showing a 122% increase from the 9 cases reported in 2022. Therefore, the rise in rabies cases is driving the growth of the imovax rabies industry. The increasing number of animal-related activities is expected to propel the growth of the imovax rabies market going forward. Animal-related activities refer to procedures involving animals for research, experimentation, breeding, and genetic alteration purposes. The rise in animal-related activities can be attributed to various factors, including increased interest in outdoor recreation, urban expansion into wildlife areas, and pet ownership and animal companionship. Animal-related activities use imovax rabies primarily for research and vaccine development to prevent and control rabies in humans and animals. For instance, in August 2025, according to U.S. Bureau of Labor Statistics, a US-based intergovernmental organization, an average of about 81,700 job openings for animal care and service workers are expected annually over the coming decade, with overall employment in this field projected to grow by 11% from 2024 to 2034. Therefore, the rise in animal-related activities is driving the growth of the imovax rabies industry. The growing pet adoption is anticipated to drive the expansion of the imovax rabies market in the future. The rise in pet ownership is driven by greater awareness of pet care, changing lifestyles, and the growing human-animal bond. Imovax rabies is used in pets for post-exposure prophylaxis or pre-exposure vaccination to protect against rabies infection. For instance, in July 2025, according to the World Animal Foundation (WAF), a US-based non-profit animal welfare organization, dog adoption rates showed a modest year-on-year uplift, increasing from 56% in 2023 to 57% in 2024, while cat adoption rates remained a strong growth driver, rising from 62% in 2023 to 64% in 2024. Therefore, the growing adoption of pets is fueling the growth of the imovax rabies industry.

Key Players In The Global Imovax Rabies Market

Major companies operating in the imovax rabies market are Sanofi SA

Regional Insights

North America was the largest region in the imovax rabies market in 2025. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Imovax Rabies Market?

The imovax rabies market consists of sales of rabies vaccine inactivated (DCO). Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Imovax Rabies Market Report 2026?

The imovax rabies market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the imovax rabies industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.